You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Endometrial Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
Has Results
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Endometrioid Endometrial Cancer Trial (Narazaciclib, Letrozole 2.5mg)

Not yet recruiting
  • Endometrioid Endometrial Cancer
  • (no location specified)
Feb 1, 2023

Circulating Tumor DNA Study in Patients With Endometrial Cancer

Recruiting
  • Endometrial Cancer
  • Whole blood
  • Paris, France
    Hôpital Cochin
Jul 12, 2023

Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)

Recruiting
  • Endometrial Cancer Recurrent
  • Crizotinib 250 MG
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Jun 6, 2022

Immunotherapy-related CRP Kinetics in Metastatic Gynecological

Recruiting
  • Gynecological Malignancies
  • +4 more
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma Trial in Houston (Futibatinib, Pembrolizumab)

    Recruiting
    • Metastatic Cancer
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma Trial in Canada, United States

    Active, not recruiting
    • Advanced Endometrial Carcinoma
    • +4 more
    • Cabozantinib S-malate
    • Nivolumab
    • Phoenix, Arizona
    • +33 more
    Nov 1, 2022

    Endometrial Tumors Trial in Spain (Pembrolizumab)

    Completed
    • Endometrial Neoplasms
    • Hospitalet de Llobregat, Barcelona, Spain
    • +6 more
    Oct 4, 2021

    Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer Trial (ART0380)

    Not yet recruiting
    • Advanced Solid Tumor
    • +2 more
    • (no location specified)
    Apr 5, 2023

    Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)

    Enrolling by invitation
    • Breast Cancer
    • +7 more
    • e-PRO monitoring
    • Kobe, Hyogo, Japan
      Kobe University Graduate School
    Jun 27, 2023

    Endometrial Cancer Trial in Copenhagen (Palbociclib/, Letrozole)

    Completed
    • Endometrial Cancer
    • Copenhagen, Sjaelland, Denmark
      NSGO-CTU
    Jan 7, 2022

    Endometrial Carcinoma Trial (Lerociclib, Letrozole 2.5mg, Placebo)

    Not yet recruiting
    • Endometrial Carcinoma
    • (no location specified)
    Jan 26, 2023

    Pattern & Outcomes of Advanced, Recurrent or Metastatic

    Completed
    • Oncology
    • +4 more
    • Argenteuil, France
    • +29 more
    Jan 23, 2023

    FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic

    Not yet recruiting
    • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
    • +4 more
    • Computed Tomography
    • +3 more
    • (no location specified)
    Sep 13, 2022

    Recurrent Endometrial Cancer Trial in France (Olaparib, metformin, metronomic cyclophosphamide)

    Completed
    • Recurrent Endometrial Cancer
    • Caen, France
    • +5 more
    Dec 6, 2021

    Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

    Not yet recruiting
    • Metastatic Endometrial Carcinoma
    • +7 more
    • Biopsy
    • +5 more
    • (no location specified)
    Jan 18, 2023

    Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the

    Completed
    Has Results
    • Triple Negative Breast Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 17, 2021

    Endometrial Cancer Trial in Nijmegen (Dendritic Cells for endometrial cancer)

    Completed
    • Endometrial Cancer
    • Dendritic Cells for endometrial cancer
    • Nijmegen, Netherlands
      Radboud University Medical Center
    May 17, 2021

    Cervical Carcinoma, Endometrial Carcinoma Trial in Salt Lake City (Hypofractionated Radiation Therapy)

    Recruiting
    • Cervical Carcinoma
    • Endometrial Carcinoma
    • Hypofractionated Radiation Therapy
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Mar 1, 2022

    Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

    Active, not recruiting
    • Advanced or Metastatic Solid Tumors
    • +8 more
    • Los Angeles, California
    • +5 more
    Nov 29, 2022

    Ovarian Tumors, Endometrial Tumors, Breast Tumors Trial in Puerto Rico, United States (PF-07260437, B7-H4 IHC)

    Recruiting
    • Ovarian Neoplasms
    • +2 more
    • Duarte, California
    • +13 more
    Jan 19, 2023

    Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer Trial in Marseille (IPH5301 ALONE OR IN COMBINATION

    Recruiting
    • Metastatic Cancer
    • +8 more
    • IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
    • Marseille, France
      Institut Paoli Calmettes
    Feb 23, 2022

    Endometrial Carcinoma Trial in Changsha, Jinan (TQB2858 injection, Anlotinib Hydrochloride capsules)

    Not yet recruiting
    • Endometrial Carcinoma
    • TQB2858 injection
    • Anlotinib Hydrochloride capsules
    • Changsha, Hunan, China
    • +1 more
    Nov 18, 2021